Complete Laparoscopic Interval Debulking Surgery for Advanced Ovarian Cancer Achieves Similar Survival Outcomes to Open Approach: A Propensity-Matched Study.


Journal

Journal of investigative surgery : the official journal of the Academy of Surgical Research
ISSN: 1521-0553
Titre abrégé: J Invest Surg
Pays: United States
ID NLM: 8809255

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 2 3 2022
medline: 3 6 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

To assess the laparoscopic interval debulking surgery (IDS) outcomes compared to laparotomy, by analyzing the overall survival (OS) and the progression free survival (PFS), as well as the intra- and post-operative morbidity. In this retrospective propensity-score-matched cohort study, all patients with stage III or IV FIGO (International Federation of Gynecology and Obstetrics) serous ovarian cancer, undergoing complete IDS after neoadjuvant chemotherapy, from January 1st of 2009 to June 1st 2019, were included. Thirty-seven patients were included in the laparoscopy group and 40 in the laparotomy group. There was no significant difference in terms of median OS between laparoscopy and laparotomy (23.1 months [95% CI 15.7-29.7] versus 26.3 months [95% CI 21.7-31.7], respectively, In carefully-selected patients with advanced ovarian cancer, complete laparoscopic interval debulking surgery achieves similar survival outcomes to open laparotomy. Therefore, laparoscopy appears as a safe alternative to laparotomy for IDS after NACT in selected patients with advanced ovarian cancer and a low burden of disease.

Identifiants

pubmed: 35227150
doi: 10.1080/08941939.2022.2045396
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1394-1401

Commentaires et corrections

Type : CommentIn

Auteurs

Lise Lecointre (L)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France.
I-Cube UMR 7357 - Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie, Université de Strasbourg, Strasbourg, France.

Madeleine Pellerin (M)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Aïna Venkatasamy (A)

IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France.
Streinth Lab (Stress Response and Innovative Therapies), Inserm UMR_S 1113 IRFAC, Interface Recherche Fondamental et Appliquée à la Cancérologie, Strasbourg, France.

Thibaut Fabacher (T)

Department of Public Health, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Lauriane Eberst (L)

Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Justine Gantzer (J)

Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Floriane Jochum (F)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Émilie Faller (É)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Thomas Boisramé (T)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Denis Querleu (D)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
IHU-Strasbourg (Institut Hospitalo-Universitaire), Strasbourg, France.
Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.

Chérif Akladios (C)

Department of Gynecologic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH